Abstract
Transfection protocols and the reagents used to deliver nucleic acids into cells can affect cell physiology, leading to misinterpretation of results. Using microarray analysis and cell viability assays, we evaluated different transfection reagents to determine their effects on gene expression profiles. Results show that FuGENE 6 Transfection Reagent exhibits very low cytotoxicity, delivers high transfection efficiency and generates few nonspecific side effects with minimal alteration in gene expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jackson, A.L. et al. Nat. Biotechnol. 21, 635–637 (2003).
Sledz, C.A. et al. Nat. Cell Biol. 5, 834–839 (2003).
Liu, H.S. et al. Biochem. Biophys. Res. Commun. 260, 712–717 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclaimer
This article was submitted to Nature Methods by a commercial organization and has not been peer reviewed. Nature Methods takes no responsibility for the accuracy or otherwise of the information provided.
Rights and permissions
About this article
Cite this article
Nagy, V., Watzele, M. FuGENE® 6 Transfection Reagent: minimizing reagent-dependent side effects as analyzed by gene-expression profiling and cytotoxicity assays. Nat Methods 3, iii–v (2006). https://doi.org/10.1038/nmeth879
Published:
Issue date:
DOI: https://doi.org/10.1038/nmeth879
